Sorla Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Sortilin-Related Receptor 1 (SORLA)
| Gene Symbol | SORLA (also SORT1) |
|---|---|
| Full Name | Sortilin Related Receptor 1 |
| Chromosomal Location | 11q13.4 |
| NCBI Gene ID | 6652 |
| OMIM | 602214 |
| Ensembl ID | ENSG00000140337 |
| UniProt ID | Q9Y6X7 |
| Associated Diseases | Alzheimer's Disease, Amyotrophic Lateral Sclerosis |
| Gene Symbol | SORLA (also SORT1) |
|---|---|
| Full Name | Sortilin Related Receptor 1 |
| Chromosomal Location | 11q13.4 |
| NCBI Gene ID | 6652 |
| OMIM | 602214 |
| Ensembl ID | ENSG00000140337 |
| UniProt ID | Q9X7 |
| Associated Diseases | Alzheimer's Disease, Amyotrophic Lateral Sclerosis |
SORLA (Sortilin-Related Receptor 1) is a neuronal sorting receptor that plays a critical role in regulating amyloid precursor protein (APP) trafficking and processing in the brain. Also known as SORL1 or Sort1, this protein is primarily expressed in neurons and acts as a key determinant of whether APP is processed along the amyloidogenic or non-amyloidogenic pathway. Genetic variants in SORLA are significant risk factors for late-onset Alzheimer's disease (AD), making it an important therapeutic target for AD prevention and treatment.
SORLA functions as a retromer-coated vesicle sorting receptor that directs proteins between the trans-Golgi network, endosomes, and the cell surface. By redirecting APP away from endosomal compartments where beta-secretase (BACE1) cleavage occurs, SORLA helps reduce amyloid-beta (Aβ) production. Reduced SORLA expression or function, as associated with certain genetic variants, leads to increased amyloidogenic processing and elevated Aβ levels—hallmarks of Alzheimer's disease pathology.
SORLA (also known as SORL1 or Sort1) is a neuronal sorting receptor that plays a critical role in regulating amyloid precursor protein (APP) trafficking and processing. The protein functions as a retromer-coated vesicle sorting receptor that directs proteins between the trans-Golgi network, endosomes, and the cell surface.
Key functions include:
SORLA contains multiple domains including a VPS10P domain (found in sorting receptors), a cluster of complement-type repeats, and a cytoplasmic tail with sorting motifs that interact with adaptor proteins.
Genetic variants in SORLA are associated with increased risk for late-onset Alzheimer's disease (LOAD). Genome-wide association studies (GWAS) have identified multiple risk alleles in the SORLA gene region:
The "Alzheimer's disease-protective" haplotype is associated with higher SORLA expression in neurons and reduced amyloid plaque burden. Animal models lacking SORLA show increased amyloid deposition, while SORLA overexpression reduces Aβ levels.
Recent studies have identified SORLA variants in ALS patients, suggesting a potential role in motor neuron disease. The exact mechanism is under investigation but may involve:
SORLA is expressed predominantly in neuronal tissues:
Expression is brain-specific with low to absent expression in peripheral tissues. SORLA expression decreases with age in human brain tissue.
The study of Sorla Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Last updated: 2026-03-04